Cancer leadership requires more than science

An Expert View from Mary Kosinski, Global Managing Director, Health & Life Sciences, FleishmanHillard.

Each September, the United Nations General Assembly serves as a reminder of both the possibilities and the fragility of international cooperation. For global health, cancer should sit at the very center of that conversation. It is universal. It cuts across politics, borders, and economies. And while the science is advancing at an extraordinary pace, the systems that should deliver those breakthroughs are failing to keep up.

This is not only a scientific challenge. It is a challenge of trust, governance, and execution. Unless leaders act with equal urgency to close the delivery gap, the most promising cancer innovations will remain locked in laboratories and conference halls rather than reaching the patients who need them.